Yuki Gosei Kogyo
Yuki Gosei Kogyo is a Japanese specialty fine chemicals manufacturer producing glycine, β-alanine, pharmaceutical APIs, organosilicon compounds, and pyridine/piperidine derivatives for pharmaceutical, food, and industrial customers across 30+ countries.
- Company typePublic
- Founded1947
- HeadquartersKoto, Japan
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Yuki Gosei Kogyo does
Yuki Gosei Kogyo is a Japanese specialty fine chemicals manufacturer founded in 1947 and listed on the Tokyo Stock Exchange Standard Market (ticker: 4531). The company operates three integrated business segments: amino acids (centered on glycine and β-alanine, with glycine first commercialized in Japan by the company in 1952), pharmaceutical active ingredients and intermediates (including isoniazid, protamine sulfate, trifluorothymidine, and generic APIs), and industrial chemicals (organosilicon compounds, pyridine and piperidine derivatives used in semiconductors, tire cord adhesives, and pesticides). Its core technology base spans amino acid synthesis, Grignard reactions, hydrogenation, and organosilicon chemistry, supported by world-scale glycine manufacturing facilities at its Tokiwa Factory in Iwaki, Fukushima.
The company monetizes primarily through direct B2B product sales of proprietary chemicals and APIs to pharmaceutical, food, and industrial customers across 30+ countries, supplemented by GMP- and ISO-compliant contract manufacturing services covering Grignard and hydrogenation chemistries. Commercial reach is structured around three specialized sales divisions covering East Japan, West Japan (Osaka office), and export markets, with a European sales hub in Düsseldorf, Germany established in 2006. Approximately 40% of total sales come from overseas markets. The company holds FDA-inspected, MHRA-cleared, and CEP-certified pharmaceutical manufacturing capabilities, Drug Master File registrations in the US, and FSSC 22000 food safety certification.
Yuki Gosei Kogyo employs approximately 296 staff as of March 2026 and maintains a wholly-owned engineering subsidiary, Yuki Techno Service Co., Ltd. The firm has reported annual net sales exceeding ¥10 billion since FY2015, with disclosed FY2026 (year ending March 2026) revenue of approximately ¥97.3 billion. Capital allocation is supported by relationships with Mitsubishi UFJ, Mizuho, Joyo Bank, and Mitsubishi UFJ Trust, and the company has executed periodic share buybacks. Recent activity includes a new mid-term management plan announced May 2026 and a collaboration with Hodogaya Chemical Industry announced February 2026.
Yuki Gosei Kogyo firmographics
Firmographics- Name
- Yuki Gosei Kogyo
- Legal name
- 有機合成薬品工業株式会社 (YUKI GOSEI KOGYO CO.,LTD.)
- Website
- https://yuki-gosei.co.jp
- Company type
- Public
- Founded year
- 1947
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Yuki Gosei Kogyo is a Japanese specialty fine chemicals manufacturer producing glycine, β-alanine, pharmaceutical APIs, organosilicon compounds, and pyridine/piperidine derivatives for pharmaceutical, food, and industrial customers across 30+ countries.
- Ownership category
- akta.pro rank
Yuki Gosei Kogyo industry classification
Industry- Product category
- Specialty Fine Chemicals
- NAICS
- Chemical Manufacturing (325), Other Basic Organic Chemical Manufacturing (32519), Medicinal and Botanical Manufacturing (325411)
- SIC
- Industrial Organic Chemicals (2860), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives) (AFABAIAI)
Keywords
Where Yuki Gosei Kogyo is headquartered
LocationHeadquarters
- HQ city
- Koto
- HQ country
- Japan
- HQ region
- Asia
Offices5 records
Markets served
Yuki Gosei Kogyo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Product sales (amino acids, pharmaceutical APIs, industrial chemicals): Sale of manufactured chemical products including glycine, β-alanine, pharmaceutical active ingredients (APIs), drug intermediates, organosilicon compounds, pyridine derivatives, and nicotinic acid amide. Core revenue driver historically exceeding ¥10 billion in annual sales since FY2015.
- Contract manufacturing services: Pharmaceutical and chemical product contract manufacturing under GMP and ISO 9000 standards. Supports BCP, cost reduction, and manufacturing capacity without customer capital investment.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels4 records
Yuki Gosei Kogyo product offering
Product offeringCore offering
Yuki Gosei Kogyo manufactures and sells organic synthetic chemical products, with core offerings centered on amino acids (notably glycine and β-alanine), pharmaceutical active ingredients, and industrial chemicals including organosilicon compounds and pyridine/piperidine derivatives. The company also provides contract manufacturing services ranging from laboratory-scale synthesis through pilot and commercial-scale production to global customers across pharmaceutical, food, and industrial sectors.
Product overview
Yuki Gosei Kogyo is a fine chemicals manufacturer offering a portfolio of specialty chemicals across three business segments: amino acids (centered on Glycine and β-Alanine), pharmaceuticals (including Isoniazid, Protamine Sulfate, and Trifluorothymidine APIs), and industrial chemicals (organosilicon compounds, pyridine derivatives, and piperidine derivatives). The company operates world-scale Glycine manufacturing facilities and provides pharmaceutical contract manufacturing services under GMP standards for export to 30+ countries. Products are sold under the company's own brands and through toll manufacturing arrangements.
Differentiator
Problem solved
Functional benefit
Products and services
- Glycine (Amino Acid)
Quantifiable outcome
- Exports to over 30 countries worldwide
- +1 more outcomes
Companies that use Yuki Gosei Kogyo
Customer profileSegments3 records
Ideal customer profiles3 records
Yuki Gosei Kogyo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Yuki Gosei Kogyo partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hodogaya Chemical Industry Co., Ltd. (保土谷化学工業株式会社)minorAnnounced collaboration with Hodogaya Chemical Industry in February 2026. Nature of collaboration not specified in available materials.
Scale indicators5 records
Recent moves13 records
Expansion highlights5 records
Yuki Gosei Kogyo competitors and assessment
Company assessmentRegional players
- Daicel Corporation: Japanese specialty chemicals manufacturer with overlapping pyridine chemistry and fine chemicals capabilities. Comparable in fine chemicals and pyridine derivatives, primarily serving Japan and Asia.
Broad incumbents
- Resonac Holdings (formerly Showa Denko): Major Japanese diversified chemicals company with semiconductor materials and specialty chemicals exposure. Comparable in organosilicon compounds and industrial chemical segments, though operates across a broader portfolio.
- Lonza Group AG: Global pharmaceutical contract manufacturing leader. Comparable in GMP API and contract manufacturing services for global pharma customers, though operating at substantially larger scale.
- Evonik Industries AG: Global specialty chemicals company with significant amino acid (including methionine and specialty amino acids) and API businesses. Comparable in custom synthesis and pharmaceutical intermediates, but operates across a much broader chemicals portfolio.
Direct peers
- Bachem Holding AG: Swiss peptide and small-molecule API manufacturer with GMP facilities serving global pharmaceutical customers. Comparable in API manufacturing, GMP compliance, and pharma contract services.
- Sigma-Aldrich (Merck KGaA): Major fine chemicals and amino acid supplier including glycine, pyridine derivatives, and piperidine compounds. Directly comparable product catalog and customer base in research, pharma, and industrial markets.
- WuXi AppTec: Leading global pharmaceutical contract research, development, and manufacturing organization. Comparable in pharmaceutical contract manufacturing, custom synthesis, and GMP API supply.
- Kyowa Hakko Bio (Kirin Holdings): Major Japanese amino acid and nucleotide producer with overlapping product families (amino acids, nucleic acids, APIs). Comparable fine chemicals manufacturer with GMP capabilities and pharma intermediates.
- Ajinomoto Co., Inc. Japanese amino acid and food ingredient major with significant glycine and β-alanine production. Directly comparable as a competing amino acid manufacturer serving food, pharma, and personal care end markets.
- Cambrex Corporation: API and small-molecule contract manufacturer serving global pharma customers under GMP. Comparable in pharmaceutical contract manufacturing services and regulatory-driven product portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Yuki Gosei Kogyo social profiles
Digital presenceYuki Gosei Kogyo compliance and trust
Trust signalCompliance11 records
Yuki Gosei Kogyo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yuki Gosei Kogyo leadership team
Management profileNumber of profiles
Profiles10 records
Yuki Gosei Kogyo subsidiaries and ownership
Company hierarchySubsidiaries1 record
Yuki Gosei Kogyo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yuki Gosei Kogyo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yuki Gosei Kogyo
What does Yuki Gosei Kogyo do?
Yuki Gosei Kogyo manufactures and sells organic synthetic chemical products, with core offerings centered on amino acids (notably glycine and β-alanine), pharmaceutical active ingredients, and industrial chemicals including organosilicon compounds and pyridine/piperidine derivatives. The company also provides contract manufacturing services ranging from laboratory-scale synthesis through pilot and commercial-scale production to global customers across pharmaceutical, food, and industrial sectors.
Is Yuki Gosei Kogyo a public or private company?
Yuki Gosei Kogyo is a public company. It is classified as public and is currently operating.
When was Yuki Gosei Kogyo founded?
Yuki Gosei Kogyo was founded in 1947. It employs 251 to 500 people.
Where is Yuki Gosei Kogyo based?
Yuki Gosei Kogyo is headquartered in Koto, Japan, in the Asia region.
How does Yuki Gosei Kogyo make money?
Two revenue lines are on record. Product sales (amino acids, pharmaceutical APIs, industrial chemicals) is the primary driver. The others are contract manufacturing services.
Who are Yuki Gosei Kogyo's main competitors?
Daicel Corporation is listed as a regional player. Broad incumbents are Resonac Holdings (formerly Showa Denko), Lonza Group AG and Evonik Industries AG. Direct peers are Bachem Holding AG, Sigma-Aldrich (Merck KGaA), WuXi AppTec, Kyowa Hakko Bio (Kirin Holdings), Ajinomoto Co., Inc. and Cambrex Corporation.
Does Yuki Gosei Kogyo have an API?
No public API is recorded for Yuki Gosei Kogyo.
What industry is Yuki Gosei Kogyo in?
Yuki Gosei Kogyo's product category is Specialty Fine Chemicals. Its primary akta.pro industry code is AFABAIAI, Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives). Its NAICS code is 325 and its SIC code is 2860.